 Effects of an angiotensin-convertingenzyme inhibitor, ramipril, on cardiovascular events in high-risk patients: the Heart Outcomes Prevention Evaluation Study Investigators.  Manual de Medicina de Familia - Página 126de Mark A. Graber, Matthew L. Lanternier - 2002 - 968 páginasVista previa restringida - Acerca de este libro
 | 2003 - 118 páginas
...Outcomes Prevention Evaluation (HOPE) Study Investigators. Effects of na angiotensin converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. N Engl J Med 2000*; 342: 145-53. 27. Collaboartive Group of the Primary Prevention Project (PPP). Low-dose aspirin... | |
 | Joan Llevadot - 2003 - 398 páginas
...the Chinese Cardiac Study (CCS-1). Lancet 1995:345:686-687. 1 57. Yusuf S, Sleight P, Pogue J et al. Effects of an angiotensin-convertingenzyme inhibitor,...ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med 2000; 342: 1 45- 1 53. 158.... | |
 | Phyllis Carolyn Leppert, Jeffrey F. Peipert - 2004 - 1000 páginas
...target organ damage and prognosis. Am / Hypertens 1993;6:2075. Yusuf S, Sleight P, Pogue J, et al. Effects of an angiotensin-converting-enzyme inhibitor,...ramipril, on cardiovascular events in high-risk patients: the Heart Outcomes Prevention Evaluation Study Investigators. N En^l } Med 2000; 342:145-153. CHAPTER... | |
 | Rhys Williams, W. Herman, A.-L. Kinmonth, N. J. Wareham - 2003 - 796 páginas
...trial. Lancet 351: 1755-62. 22. The Heart Outcomes Prevention Evaluation Study Investigators (2000) Effects of an angiotensin-converting-enzyme inhibitor,...ramipril, on cardiovascular events in high-risk patients. New Eng. J. Med. 342: 145-53. 23. Heart Outcomes Prevention Evaluation (HOPE) Study Investigators (2000)... | |
 | Steven P. Marso, David M. Stern (M.D.) - 2004 - 554 páginas
...diabetes mellitus: lessons learned from ACE inhibition. Circulation 1998:97:12-15. 195. Yusuf S, et al. Effects of an angiotensin-convertingenzyme inhibitor,...ramipril, on cardiovascular events in high-risk patients: the Heart Outcomes Prevention Evaluation study investigators. N Engl J Med 2000:342: 145-153. 196.... | |
 | Irene D. Turpie, George A. Heckman - 2004 - 242 páginas
...hypertrophy. Hypertension 1996;28:988994. 140. Yusuf S, Sleight P, Pogue J, Bosch J, Davies R, Dagenais G. Effects of an angiotensinconverting-enzyme inhibitor,...ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med 2000;342: 145-1 53. 141.... | |
 | R. Sean Morrison, Diane E. Meier - 2003 - 464 páginas
...individuals with previous stroke or transient ischaemic attack. Lancet 358:10331041, 2001. 50. Yusuf S. Effects of an angiotensinconverting-enzyme inhibitor,...ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med 342:145-153, 2000. 51. Joint... | |
 | Michael K. Pugsley - 2008 - 427 páginas
...38, 1130-1136. 90. Yusuf, S., Sleight, P., Pogue, J., Bosch, J., Davies, R., and Dagenais, G. (2000) Effects of an angiotensin-converting-enzyme inhibitor,...ramipril, on cardiovascular events in highrisk patients. The Heart Outcomes Prevention Evaluation Study Investigators. TV. Engl. J. Med. 342, 145-153. 91. Hink,... | |
 | Donald Hricik, Michael Smith, Jackson Wright - 2003 - 180 páginas
...Heart Outcomes Prevention Evaluation Study Investigators: Effects of an angiotensin-converting enzyme inhibitor. ramipril. on cardiovascular events in high-risk patients. N Engl J Med 342:145-153.2000. 6. Hricik DE, Browning PJ, Kopelman R. et al: Captopril-induced functional renal... | |
 | Joel D. Kopple, Shaul G. Massry - 2004 - 716 páginas
...randomised placebo-controlled trial. Lancet 2000:356:1213-1218. 132. Yusuf S, Sleight P, Pogue J, et al. Effects of an angiotensinconverting-enzyme inhibitor,...ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N EnglJ Med 2000:342: 145- 153. 133.... | |
| |
